The South Korea Immunoassay Market is preparing for long-term expansion supported by global export initiatives and intelligent diagnostic integration. Advanced automated systems and precision biomarkers are expected to dominate clinical protocols, especially for oncology, metabolic health, and infectious diseases. This outlook is reinforced by technological strategies highlighted in South Korea...